USA flag logo/image

An Official Website of the United States Government

New Reagents for RNA-based Therapeutic Technologies

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2013 / SBIR
Agency Tracking Number:
R43DK099026
Solicitation Year:
2013
Solicitation Topic Code:
NIDDK
Solicitation Number:
PA12-088
Small Business Information
GENOMEX
231-J E. Johnson St CARY, NC 27513-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2013
Title: New Reagents for RNA-based Therapeutic Technologies
Agency: HHS
Contract: 1R43DK099026-01A1
Award Amount: $182,864.00
 

Abstract:

DESCRIPTION (provided by applicant): The goal of this Phase I effort is determine the feasibility of developing a unique antimicrobial catheter to reduce the instances of the most prevalent healthcare associated infection, Catheter-Associated Urinary TractInfection (CAUTI). This research and development effort will be to develop a urinary catheter with inherent long lasting antiseptic properties to protect the patient and prevent infection. The proposed device is a new approach to antimicrobial catheters.It will use common Foley catheter designs and materials, with the addition of an additive to the elastomer to render the catheter antimicrobial. The additive replaces the silica reinforcing filler in the elastomer and is designed to give a long lasting time release of antibacterial agent to the catheter surface. The catheter can be manufactured inexpensively with standard medical tubing manufacturing processes and materials, but will have the value-added property of antimicrobial activity. A durable and effective antimicrobial catheter that can prevent or reduce CAUTI will save millions of dollars in healthcare cost and thousands of lives annually. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: A top priority of the Health and Human Services and the National Institutes of Health is the elimination of Healthcare Associated Infections (HAI). Catheter-associated urinary tract infection (CAUTI), the most prevalent HAI, is the source of over 30% of all HAI's. There are approximately 560,000 cases ofCAUTI resulting an estimated 13,000 deaths annually in the US. The resulting increased hospital stay and increased antibiotic use results in an annual cost of over 0.5 billion dollars to US healthcare.

Principal Investigator:

Joel L. Williams
919-467-1473
pollyman4u@aol.com

Business Contact:

Paul M. Vernon
919-467-0180
pmvernon@bellsouth.net
Small Business Information at Submission:

GENOMEX
231-J E. Johnson St CARY, NC 27513-

EIN/Tax ID: 156212897
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No